Patents by Inventor Kathleen Anne Derwin

Kathleen Anne Derwin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10004586
    Abstract: Biocompatible tissue grafts are provided. The biocompatible tissue grafts include a bulk graft including a biocompatible material and having at least a first surface. The biocompatible tissue grafts also include a coating including a hydrogel and being immobilized on the bulk graft at the first surface. The biocompatible material includes at least one of a biologic material or a biologic-synthetic composite material. The hydrogel includes cross-linked hydroxyphenyl-substituted hyaluronan (HPS-HA), cross-linked hydroxyphenyl-substituted collagen (HPS-C), or both. The cross-linked HPS-HA, cross-linked HPS-C, or both have been formed by cross-linking of hydroxyphenyl groups of HPS-HA, HPS-C, or both to form dihydroxyphenyl bridges. Also disclosed are methods for repair of tissue damage in a subject in need thereof. The methods include surgically implanting the biocompatible tissue graft into a site of the tissue damage in the subject.
    Type: Grant
    Filed: August 27, 2015
    Date of Patent: June 26, 2018
    Assignee: The Cleveland Clinic Foundation
    Inventors: Kathleen Anne Derwin, Anthony Calabro
  • Publication number: 20160058534
    Abstract: Biocompatible tissue grafts are provided. The biocompatible tissue grafts comprise a bulk graft comprising a biocompatible material and having at least a first surface. The biocompatible tissue grafts also comprise a coating comprising a hydrogel and being immobilized on the bulk graft at the first surface. The biocompatible material comprises at least one of a biologic material or a biologic-synthetic composite material. The hydrogel comprises cross-linked hydroxyphenyl-substituted hyaluronan (HPS-HA), cross-linked hydroxyphenyl-substituted collagen (HPS-C), or both. The cross-linked HPS-HA, cross-linked HPS-C, or both have been formed by cross-linking of hydroxyphenyl groups of HPS-HA, HPS-C, or both to form dihydroxyphenyl bridges. Also disclosed are methods for repair of tissue damage in a subject in need thereof. The methods comprise surgically implanting the biocompatible tissue graft into a site of the tissue damage in the subject.
    Type: Application
    Filed: August 27, 2015
    Publication date: March 3, 2016
    Inventors: Kathleen Anne Derwin, Anthony Calabro
  • Patent number: 8080260
    Abstract: A composition comprising a human- or animal-derived extracellular matrix and a macromolecular network which is prepared ex vivo is provided that is useful in the repair of a tissue injury, particularly in repair of tears or gaps between a tendon and a bone, such as in a rotator cuff tear. In an embodiment, the composition comprises a human- or animal-derived extracellular matrix having impregnated therein a macromolecular network of hyaluronan macromolecules that have been cross-linked via dihydroxyphenyl linkages, so that the cross-linked network is interlocked within the extracellular matrix. The resulting HA-incorporated extracellular matrix can be supplied in the form of a patch to reinforce a tissue repair or cover a tissue defect.
    Type: Grant
    Filed: February 13, 2009
    Date of Patent: December 20, 2011
    Assignee: The Cleveland Clinic Foundation
    Inventors: Kathleen Anne Derwin, Joseph Patrick Iannotti, LiKang Chin, Anthony Calabro
  • Publication number: 20090204227
    Abstract: A composition comprising a human- or animal-derived extracellular matrix and a macromolecular network which is prepared ex vivo is provided that is useful in the repair of a tissue injury, particularly in repair of tears or gaps between a tendon and a bone, such as in a rotator cuff tear. In an embodiment, the composition comprises a human- or animal-derived extracellular matrix having impregnated therein a macromolecular network of hyaluronan macromolecules that have been cross-linked via dihydroxyphenyl linkages, so that the cross-linked network is interlocked within the extracellular matrix. The resulting HA-incorporated extracellular matrix can be supplied in the form of a patch to reinforce a tissue repair or cover a tissue defect.
    Type: Application
    Filed: February 13, 2009
    Publication date: August 13, 2009
    Applicant: The Cleveland Clinic Foundation
    Inventors: Kathleen Anne Derwin, Joseph Patrick Iannotti, LiKang Chin, Anthony Calabro